Cytomedix, Inc. CMXI Company Overview  Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Cytomedix, Inc. CMXI Company Overview 

Stock Message Board http://investorshangout.com/search?q=CMXI&...mp;yt1=Go!

Cytomedix, Inc. CMXI Current Price and Quotes
0.42
Previous Close
0.41
Open
0.41

Daily Range
0.42 - 0.41
52wk Range
1.24 - 0.37

Volume
196,784
Dividend
N/A

Average Vol (3m)
70,304
Yield
N/A

Cytomedix, Inc. CMXI
Company Information
209 Perry Parkway
Suite 7
Gaithersburg, MD 20877

Website: http://www.cytomedix.com
Phone: 240-499-2680
Email: info@cytomedix.com

Cytomedix, Inc. CMXI
Cytomedix, Inc. develops and commercializes innovative autologous therapies that promote healing by harnessing the innate and regenerative capacity of platelets and adult stem cells.

Cytomedix, Inc. CMXI
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001091596
Fiscal Year End 12/31
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: DE, USA
Year of Inc. 1998
Employees 35 a/o Aug 01, 2012
Company Officers/Contacts
David E. Jorden IR
Martin P. Rosendale CEO
Edward L. Field COO
Steven Shallcross CFO
Company Directors
David E. Jorden Executive Chairman
James S. Benson
Joseph Del Guercio
Lyle A. Hohnke
Stephen N. Keith
Richard S. Kent
Mark T. McLoughlin
Martin P. Rosendale
C. Eric Winzer
Company Notes
Note = Company delisted from NYSE Amex on 01/26/11
Note=8-01 company filed petition under Chapter XI of the Federal Bankruptcy Code in the U.S. Bankruptcy Court for the Northern District of Illinois, Eastern Division. Case No. 01-27610. First Amended Plan of Reorganization effective 7-11-02: 1 for 5 reverse split implemented 7-26-02; Holders of Com (Old) to exchange every 5 shs (Old) for 1 sh Com (New)
Formerly=Autologous Wound Therapy, Inc. until 4-00
Formerly=Informatix Holdings, Inc. until 11-99
Formerly=Music & Entertainment Network, Inc. until 7-98
Service Providers
DAD/PAL
C. K. Cooper & Company
18300 Von Karman Ave; Suite 700
Irvine, CA, 92612
United States

Auditor/Accountant
Stegman & Company, Professional Association
405 East Joppa Road
Suite 200
Baltimore, MD, 21286
United States

Legal Counsel
Cozen O'Connor
1627 I Street, Suite 1100
Washington D.C., DC, 20006
United States

Investor Relations Firm
Lippert/Heilshorn & Associates
800 Third Avenue
New York, NY, 10022
United States


Cytomedix, Inc. CMXI
CMXI Security Details
Share Structure
Market Value1 $31,659,690 a/o Aug 30, 2013
Shares Outstanding 75,380,214 a/o Aug 05, 2013
Float 66,193,992 a/o Aug 10, 2012
Authorized Shares 160,000,000 a/o May 21, 2012
Par Value  0.0001
Shareholders
Shareholders of Record 506 a/o Mar 29, 2012
Security Notes
Issued=7-02 Pursuant to reorganization out of bankruptcy. Holders of Com (Old) are to exchange their certificates for new certificates on the basis of a 1 for 5 reverse split
Delisted from NYSE Amex on 01/26/11
Capital Change=shs decreased by 1 for 5 split. Pay date=07/26/2002.
Short Selling Data
Short Interest 214,119 (0.69%)
Aug 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)
Broadridge Financial Solutions, Inc.

Cytomedix, Inc. CMXI Recent News


Aug 17, 2013 OTC Daily Alert Stock Watch - Cytomedix, Inc (OTCQX: CMXI)
Aug 8, 2013 Cytomedix Announces Second Quarter 2013 Financial Results and Commercial Partnership for Angel(R) Technology
Aug 2, 2013 Cytomedix to Host Second Quarter 2013 Financial Results Conference Call on Thursday, August 8, 2013
Jul 10, 2013 Centers for Medicare and Medicaid Services Issues Proposed Payment Rules Affecting AutoloGel(TM) for Chronic Non-Healing Wounds


Cytomedix, Inc. CMXI Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 10,564 7,247 3,911 2,066
Cost of Revenue 3,915 2,727 1,613 459
Gross Profit 6,650 4,520 2,298 1,607
Operating Expenses
Research and Development 3,386 98 416 227
Sales, General and Admin. 16,158 7,936 7,285 4,829
Non-Recurring Items - - - -
Other - - - -
Operating Income (12,895) (3,514) (5,403) (3,449)
Income From Continuing Operations
Add'l Income/Expense Items (5,844) 1,070 (601) 180
Earnings Before Interest and Tax (18,739) (2,444) (6,004) (3,259)
Interest Expense 1,042 1,048 799 -
Earnings Before Tax (19,780) (3,493) (6,803) (3,259)
Income Tax 18 18 14 -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (19,798) (3,511) (6,817) (3,259)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (19,798) (3,511) (6,817) (3,259)
Preferred Stock and Other Adjustments (14) (346) (2,223) (15)
Net Income Applicable to Common Shareholders (19,812) (3,857) (9,040) (3,274)

CMXI Cytomedix, Inc. Research DD Guide

CMXI Cytomedix, Inc. Stock Message Board http://investorshangout.com/search?q=CMXI&...mp;yt0=Go!
CMXI Cytomedix, Inc. Stock Quote http://www.otcmarkets.com/stock/CMXI/quote
CMXI Cytomedix, Inc. Stock Chart http://www.otcmarkets.com/stock/CMXI/chart
CMXI Cytomedix, Inc. Company Info http://www.otcmarkets.com/stock/CMXI/company-info
CMXI Cytomedix, Inc. Recent News http://www.otcmarkets.com/stock/CMXI/news
CMXI Cytomedix, Inc. Financials http://www.otcmarkets.com/stock/CMXI/financials
CMXI Cytomedix, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/CMXI/filings
CMXI Cytomedix, Inc. Short Sales http://www.otcmarkets.com/stock/CMXI/short-sales
CMXI Cytomedix, Inc. Insider Disclosure http://www.otcmarkets.com/stock/CMXI/insider-transactions
CMXI Cytomedix, Inc. Research Reports http://www.otcmarkets.com/stock/CMXI/research
CMXI Cytomedix, Inc. Summary http://finance.yahoo.com/q?s=CMXI
CMXI Cytomedix, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=CMXI+Historical+Prices
CMXI Cytomedix, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=CMXI
CMXI Cytomedix, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=CMXI+Basic+Chart
CMXI Cytomedix, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CMXI+Basic+Tech.+Analysis
CMXI Cytomedix, Inc. Headlines http://finance.yahoo.com/q/h?s=CMXI+Headlines
CMXI Cytomedix, Inc. Press Releases http://finance.yahoo.com/q/p?s=CMXI+Press+Releases
CMXI Cytomedix, Inc. Company Profile http://finance.yahoo.com/q/pr?s=CMXI+Profile
CMXI Cytomedix, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=CMXI+Key+Statistics
CMXI Cytomedix, Inc. Industry http://finance.yahoo.com/q/in?s=CMXI+Industry
CMXI Cytomedix, Inc. Major Holders http://finance.yahoo.com/q/mh?s=CMXI+Major+Holders
CMXI Cytomedix, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=CMXI+Insider+Transactions
CMXI Cytomedix, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=CMXI+Insider+Roster
CMXI Cytomedix, Inc. Income Statement http://finance.yahoo.com/q/is?s=CMXI
CMXI Cytomedix, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=CMXI
CMXI Cytomedix, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=CMXI+Cash+Flow&annual
CMXI Cytomedix, Inc. Nasdaq http://www.nasdaq.com/symbol/CMXI
CMXI Cytomedix, Inc. Market Watch http://www.marketwatch.com/investing/stock/CMXI
CMXI Cytomedix, Inc. Bloomberg http://www.bloomberg.com/quote/CMXI:US
CMXI Cytomedix, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=CMXI
CMXI Cytomedix, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=CMXI
CMXI Cytomedix, Inc. Barchart http://www.barchart.com/quotes/stocks/CMXI
CMXI Cytomedix, Inc. OTC Short Report http://otcshortreport.com/index.php?index=CMXI
CMXI Cytomedix, Inc. Investopedia http://www.investopedia.com/markets/stocks/CMXI/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Atlas Unveils Luxurious Owner's Suites on New Yacht

Updated Category News Views 4

Set Sail into Opulent Luxury The upcoming debut of the Atlas Adventurer yacht promises to redefine luxury at sea with its exclusive Owner's Suites. Yeah, you heard that right—these aren't your average cabins. Atlas Ocean Voyages is shooting for the stars here, rolling out the yacht's crown jewel of accommodations that's got everyone buzzing. Nestled on Deck 6, above the...

Continue Reading
Mixed Wage Growth: Gains for Some, Challenges Persist

Updated Category News Views 3

A Closer Look at Q3 Earnings I tell you, these numbers from the Ludwig Institute make for a pretty mixed bag. Sure, we got a slight nudge upwards in those median weekly earnings for the third quarter, like from $1,035 to $1,041. It’s a pinch of positive news, but hang on a sec before you start celebrating. The reality ain't shifting for a lot of folks, especially if...

Continue Reading
LFG Charts New Path with Expanded Franchise Lineup

Updated Category News Views 4

A Unique Approach to Franchise Expansion LFG, or Limitless Franchise Growth if you prefer function over flair, is taking its expansion game to a different level. Based out of Scottsdale, these savvy folks have just beefed up their portfolio to nine diverse brand partners. You’d think they’re all about boosting numbers, right? But nah, they're so picky you'd think...

Continue Reading
TransPerfect Launches College Bowl Game in Puerto Rico

Updated Category News Views 3

Puerto Rico Welcomes College Football with Open Arms Imagine kicking towards the goalposts while the ocean breeze kisses your face—yep, that's what's happening in Puerto Rico this December. TransPerfect, a heavyweight in language and tech solutions, is rolling out the red carpet for the inaugural TransPerfect San Juan Bowl, and it’s not just a game. It’s a bold step...

Continue Reading
Low GWP Refrigerants: Potential $13B Market by 2031

Updated Category News Views 4

Refrigerants: They're Hot in More Ways Than One Who would've thought refrigerants could be such a big deal? But here we are. The low global warming potential (GWP) refrigerants market is heating up, projected to jump from $8.17 billion in 2026 to a whopping $13.06 billion by 2031. That's a solid 9.8% CAGR if you're keeping score. The drivers? Well, we’ve got...

Continue Reading
Tucows Preps for Q3 Financial Reveal on November 5th

Updated Category News Views 4

A New Financial Landscape Unfolds Ah, another earnings season looms on the horizon, and Tucows Inc. has flagged November 5, 2026, as the day the curtain rises for its third-quarter financial results. Right after the market closes at exactly 5:05 p.m. ET, Tucows plans to dish out its numbers, giving investors and analysts the meat and potatoes they crave by way of a news...

Continue Reading
Haystack Expands MCP to Boost AI Intranet Workflow

Updated Category News Views 10

Bridging the Intranet and AI: A Game Changer? You ever feel like your company's intranet is a black hole, swallowing all the information you need before spitting it back out in a chaos of outdated pages and broken links? Well, Haystack aims to clear that fog with their Model Context Protocol (MCP) server. And starting October 26, the game takes a leap forward. Now, not...

Continue Reading
D-Wave Investors Face Pressure Ahead of December 15

Updated Category News Views 0

Investors Eye December 15 Deadline Nothing like a looming deadline to stir up some anxiety among investors, and that's exactly what's going down at D-Wave Quantum Inc. right now. We're talking about the class action lawsuit spearheaded by the firm Robbins Geller Rudman & Dowd LLP. They've sent out a call to arms for investors who suffered significant losses from February...

Continue Reading
Revolutionizing Textiles: Touchscreen Garments Emerge

Updated Category News Views 5

Picture a world where your shirt does more than just cover your back. Bingo, folks—smart textiles have taken center stage with groundbreaking technology that melds touchscreens with fabric, and the brains behind it hail from the National University of Singapore (NUS). It's not just about slapping a few LEDs onto a vest. We're talking about clothing that can display...

Continue Reading
California Waste Solutions: Investing in Vietnam's Future

Updated Category News Views 2

Some folks see trash. David Duong sees hope—and dollar signs. This man ain't just talking trash collection; he's flipping waste into opportunity and, more importantly, into core community building in Vietnam. Over at Vietnam Waste Solutions, a subsidiary of California Waste Solutions, they're blending environmental breakthroughs with good old-fashioned community values....

Continue Reading

Top 5 Most Recently Viewed Articles

GDI Integrated Facility Services Underscores Financial Resilience

Updated Category News Views 201

Financial Performance Overview GDI Integrated Facility Services Inc. recently provided a detailed account of its financial performance for the second quarter of 2025, revealing significant revenue metrics and underlying trends. Quarterly Revenue Analysis During this period, GDI reported a revenue of $610 million, marking a decrease of $29 million or 5% compared to the...

Continue Reading
Marin, Barrett, and Murphy Law Firm Unveils Enhanced Website Experience

Updated Category News Views 47

Marin, Barrett, and Murphy Law Firm Launches New Website The Marin, Barrett, and Murphy Law Firm is thrilled to reveal their newly redesigned website, dedicated to providing clients with premier criminal defense services. This new website reflects the firm’s commitment to offering experienced legal representation and transparent communication, arming clients with the...

Continue Reading
Veradigm Board Transition: Beth Altman's Departure Explained

Updated Category News Views 376

Veradigm Board Transition and Leadership Changes Veradigm® (OTCMKTS: MDRX), a notable leader in healthcare technology solutions, has recently experienced a significant transition in its Board of Directors with the resignation of Beth Altman. This decision was attributed to health reasons and marks a pivotal moment for the company as they continue their commitment to...

Continue Reading
Pfizer's Future: Strategic Initiatives and Market Outlook

Updated Category News Views 1753

Pfizer's Strategic Overview Pfizer Inc. (NYSE: PFE), a well-known global pharmaceutical leader, faces a pivotal moment as it transitions from the pandemic era towards sustainable growth. The company's stock has displayed volatility, thereby necessitating a comprehensive exploration of its strategic maneuvers, product pipelines, and overall market stance. In this analysis,...

Continue Reading
Important Financial Dates to Note for Glunz & Jensen Holding

Updated Category News Views 102

Key Financial Announcements for Glunz & Jensen Holding A/S Glunz & Jensen Holding A/S is dedicated to keeping its shareholders and stakeholders well-informed about their financial activities. By sharing their financial calendar, they ensure that everyone involved can plan accordingly for essential updates and meetings. Upcoming Financial Reporting Schedule Mark your...

Continue Reading